Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

347 ARTíCULOS , VIENDO DEL 1 AL 15

PUBMED

Microbiome profiling reveals gut dysbiosis in a transgenic mouse model of Huntington's disease.

Kong G, Cao KL, Judd LM, Li S, Renoir T, Hannan AJ.

Neurobiol Dis. 2020 Feb;135:104268. doi: 10.1016/j.nbd.2018.09.001. Epub 2018 Sep 5.

0

0

0

PUBMED

Predictors of simulated driving performance in Huntington's disease.

Jacobs M, Hart EP, Mejia Miranda Y, Groeneveld GJ, van Gerven JMA, Roos RAC.

Parkinsonism Relat Disord. 2018 Oct 1. pii: S1353-8020(18)30433-4. doi: 10.1016/j.parkreldis.2018.10.002. [Epub ahead of print]

0

0

0

PUBMED

Early Neurodegeneration in R6/2 Mice Carrying the Huntington's Disease Mutation with a Super-Expanded CAG Repeat, Despite Normal Lifespan.

Kielar C, Jennifer Morton A.

J Huntingtons Dis. 2018;7(1):61-76. doi: 10.3233/JHD-170265.

0

0

0

PUBMED

Social Cognition and Oxytocin in Huntington's Disease: New Insights.

Unti E, Mazzucchi S, Frosini D, Pagni C, Tognoni G, Palego L, Betti L, Miraglia F, Giannaccini G, Ceravolo R.

Brain Sci. 2018 Aug 26;8(9). pii: E161. doi: 10.3390/brainsci8090161.

0

0

0

PUBMED

Direct assessment of presynaptic modulation of cortico-striatal glutamate release in a Huntington's disease mouse model.

Koch ET, Woodard CL, Raymond LA.

J Neurophysiol. 2018 Oct 17. doi: 10.1152/jn.00638.2018. [Epub ahead of print]

0

0

0

PUBMED

Mutational analysis implicates the amyloid fibril as the toxic entity in Huntington's disease.

Drombosky KW, Rode S, Kodali R, Jacob TC, Palladino MJ, Wetzel R.

Neurobiol Dis. 2018 Aug 29. pii: S0969-9961(18)30508-4. doi: 10.1016/j.nbd.2018.08.019. [Epub ahead of print]

0

0

0

PUBMED

Quality of life in Huntington's disease: Critique and recommendations for measures assessing patient health-related quality of life and caregiver quality of life.

Mestre TA, Carlozzi NE, Ho AK, Burgunder JM, Walker F, Davis AM, Busse M, Quinn L, Rodrigues FB, Sampaio C, Goetz CG, Cubo E, Martinez-Martin P, Stebbins GT; Members of the MDS Committee on Rating Sca

Mov Disord. 2018 Mar 23. doi: 10.1002/mds.27317. [Epub ahead of print] Review.

0

0

0

PUBMED

Customized Dietary Intervention Avoids Unintentional Weight Loss and Modulates Circulating miRNAs Footprint in Huntington's Disease.

Aganzo M, Montojo MT, López de Las Hazas MC, Martínez-Descals A, Ricote-Vila M, Sanz R, González-Peralta I, Martín-Hernández R, de Dios O, Garcés C, Galdón A, Lorenzo Ó, Tomás-Zapico C, Dávalos A, Váz

Mol Nutr Food Res. 2018 Oct 25:e1800619. doi: 10.1002/mnfr.201800619. [Epub ahead of print]

0

0

0

PUBMED

Improvement of BDNF signalling by P42 peptide in Huntington's disease.

Couly S, Paucard A, Bonneaud N, Maurice T, Benigno L, Jourdan C, Cohen-Solal C, Vignes M, Maschat F.

Hum Mol Genet. 2018 Jun 1. doi: 10.1093/hmg/ddy207. [Epub ahead of print]

0

0

0

PUBMED

Atrophy of the putamen at time of clinical motor onset in Huntington's disease: a 6-year follow-up study.

Coppen EM, van der Grond J, Roos RAC.

J Clin Mov Disord. 2018 Mar 23;5:2. doi: 10.1186/s40734-018-0069-3. eCollection 2018.

0

0

0

PUBMED

Neuroprotective activity of tetramethylpyrazine against 3-nitropropionic acid induced Huntington's disease-like symptoms in rats.

Danduga RCSR, Dondapati SR, Kola PK, Grace L, Tadigiri RVB, Kanakaraju VK.

Biomed Pharmacother. 2018 Sep;105:1254-1268. doi: 10.1016/j.biopha.2018.06.079. Epub 2018 Jun 22.

0

0

0

PUBMED

Intravenous immunoglobulin ameliorates motor and cognitive deficits and neuropathology in R6/2 mouse model of Huntington's disease by decreasing mutant huntingtin protein level and normalizing NF-κB signaling pathway.

Liu SY, Yu XL, Zhu J, Liu XM, Zhang Y, Dong QX, Ma S, Liu RT.

Brain Res. 2018 Jun 11. pii: S0006-8993(18)30336-6. doi: 10.1016/j.brainres.2018.06.009. [Epub ahead of print]

0

0

0

PUBMED

Stem cell transplantation for Huntington's diseases.

Choi KA, Choi Y, Hong S.

Methods. 2018 Jan 15;133:104-112. doi: 10.1016/j.ymeth.2017.08.017. Epub 2017 Sep 1. Review.

0

0

0

PUBMED

Mouse model of chorea-acanthocytosis exhibits male infertility caused by impaired sperm motility as a result of ultrastructural morphological abnormalities in the mitochondrial sheath in the sperm midpiece.

Nagata O, Nakamura M, Sakimoto H, Urata Y, Sasaki N, Shiokawa N, Sano A.

Biochem Biophys Res Commun. 2018 Jun 21. pii: S0006-291X(18)31408-6. doi: 10.1016/j.bbrc.2018.06.096. [Epub ahead of print]

0

0

0

PUBMED

Indoleamine 2,3-dioxygenase as a novel therapeutic target for Huntington's disease.

Boros FA, Klivényi P, Toldi J, Vécsei L.

Expert Opin Ther Targets. 2018 Nov 22:1-13. doi: 10.1080/14728222.2019.1549231. [Epub ahead of print]

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy